Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Aptensio XR® in Children Ages 4 to Under 6 Years Diagnosed With Attention Deficit-Hyperactivity Disorder (ADHD)
NCT02683265 is registered in ClinicalTrials.gov with Rhodes Pharmaceuticals, L.P. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Aptensio XR® in Children Ages 4 to Under 6 Years Diagnosed With Attention Deficit-Hyperactivity Disorder (ADHD)
- Lead sponsor
- Rhodes Pharmaceuticals, L.P.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 25, 2016
- Completion date
- March 27, 2018
- Enrollment
- 158 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.